Suscribirse

Medium-term evaluation of leg lengthening by ISKD® intramedullary nail in 28 patients: Should we still use this lengthening system? - 12/11/20

Doi : 10.1016/j.otsr.2020.06.007 
Paul Lecoanet a, , Yohan Legallois a, Clément Ribes b, Yan Lefevre a, Adrien Cadennes a, Thierry Fabre a
a CHU Bordeaux, place Amélie Raba-Léon, 33000 Bordeaux, France 
b Hôpital d’Instruction des Armées Robert Picqué, 351, route de Toulouse, 33140 Villenave-d’Ornon, France 

Corresponding author at: Service d’Orthopédie, CHU Bordeaux, place Amélie Raba-Léon, 33000 Bordeaux, France.Service d’Orthopédie, CHU Bordeauxplace Amélie Raba-LéonBordeaux33000France

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Introduction

Lower-limb lengthening presently uses intramedullary nailing. There are motorized systems and mechanical systems, each with their specific complications. The aim of the present study was to assess the efficacy of ISKD® mechanical nails (Orthofix Inc., Texas, USA) on 3D EOS® imaging, and also complications and functional impact.

Hypothesis

The study hypothesis was that nail lengthening is effective but should no longer use the ISKD® system, due to the high rate of specific complications.

Material and methods

A single-center retrospective study included 28 patients (14 female, 14 male) undergoing limb-lengthening by ISKD® nail between 2005 and 2018. Mean age was 29 years. Twenty-four procedures were femoral and 4 tibial. Lengthening and consolidation parameters and residual discrepancy were measured on 3D EOS® imaging. Complications and functional scores were collated.

Results

Twenty-eight ISKD® nails were implanted in 28 patients. Mean follow-up was 75 months. Planned lengthening was achieved in 78.5% of cases, for a mean lengthening of 34.5mm. Mean lengthening and consolidation indices were respectively 0.94mm/day and 105 days/cm. Length discrepancy showed significant correction, with improvement in functional scores (p<0.01). The overall complications rate was 67.9%, 76% of which were specific to the ISKD® nail.

Discussion

The present study confirmed that nail lengthening is an indication of choice in lower-limb length discrepancy, but that the ISKD® system should no longer be used, due to an excessive rate of specific complications. Complications are due to deficient control of lengthening rate, not found with new-generation motorized nails, which show much fewer complications.

Level of evidence

IV, retrospective study without control group.

El texto completo de este artículo está disponible en PDF.

Keywords : LLLD, Bone lengthening, Mechanical distraction nail, ISKD®, EOS®


Esquema


© 2020  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 7

P. 1433-1440 - novembre 2020 Regresar al número
Artículo precedente Artículo precedente
  • Results of femoral neck screw fixation in 112 under 65-years-old at a minimum 2 years’ follow-up
  • Roger Erivan, Guillaume Fassot, Guillaume Villatte, Aurélien Mulliez, Stéphane Descamps, Stéphane Boisgard
| Artículo siguiente Artículo siguiente
  • Orthogeriatric assessment of patients over 75 years of age with a proximal femur fracture: Predictors of 6-month mortality
  • Camille Collin, Charlotte Bimou, Christian Mabit, Achille Tchalla, Jean-Louis Charissoux, Pierre-Sylvain Marcheix

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.